Jaclyn Liu +1 (415) 268-6722 jliu@mofo.com |
Via EDGAR |
March 29, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: |
Robert Augustin |
|||
Jane Park |
Re: | Axogen, Inc. |
Registration Statement on Form S-3 |
Filed March 6, 2024 |
File No. 333-277689 |
Ladies and Gentlemen:
On behalf of Axogen, Inc. (the Company), we are providing this letter in response to the comment (the Comment) received from the staff (the Staff) of the U.S. Securities and Exchange Commissions Division of Corporation Finance (the Commission) by letter dated March 18, 2024 with respect to the above-referenced Registration Statement on Form S-3 (File No. 333-277689) filed with the Commission on March 6, 2024 (the Registration Statement).
Concurrently with the submission of this letter, the Company is filing through the Commissions Electronic Data Gathering, Analysis and Retrieval (EDGAR) system, an amendment to the Registration Statement (the Amendment) in response to the Comment and to reflect certain other changes.
Set forth below are the Companys responses to the Comment. For the Staffs convenience, the Comment is set forth below in italics.
Registration Statement on Form S-3
Selling Securityholders, page 28
1. | You indicate that you are registering $100 million of securities on behalf of the company and selling securityholders. On page 28, you disclose that [i]nformation about selling securityholders, where applicable, will be set forth in a prospectus supplement, in a post-effective amendment or in filings we make with the SEC under the Exchange Act that are incorporated by reference. Please revise to identify the initial transaction(s) pursuant to which the securities the selling securityholders are offering were originally sold. Please also clarify that the initial offering was completed and the securities were issued and outstanding prior to filing this registration statement on Form S-3. Revise your fee table, prospectus cover page and elsewhere as appropriate to disclose the aggregate number of shares being registered for resale. File a revised legal opinion that covers the securities to be offered for resale by the selling securityholders. Refer to Securities Act Rule 430B(b)(2) and General Instruction II.G of Form S-3. For additional guidance, refer to Questions 228.03 and 228.04 of our Securities Act Rules Compliance and Disclosure Interpretations. |
United States Securities and Exchange Commission
March 29, 2024
Page 2
Response to Comment 1:
The Company respectfully acknowledges the Staffs comment and has revised the Amendment to remove all references to selling securityholders.
Please contact me at (415) 268-6722 with any questions or further comments regarding our responses to the Staffs Comment.
Sincerely,
Morrison & Foerster LLP
/s/ Jaclyn Liu |
Jaclyn Liu |
cc: | Marc Began, Axogen, Inc. |
2